Cochrane · systematic review · CD013560

Antidepressant treatment for postnatal depression

Brown, JV, Wilson, CA, Ayre, K, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library

Common Mental DisordersAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
37
current version
GRADE rated
22
No studies
15
Included studies
NR
No studies 15 · 40.5%Ungraded 0 · 0%Very low 12 · 32.4%Low 10 · 27%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Antidepressants versus placebo for postnatal depression

Population: women of any age, with PND up to 12 months
7 questions
OutcomeEffectEvidenceStatus / GRADE
Depression response (acute, 5 ≤ 12 weeks)
Antidepressants vs placebo
RR 1.27 [0.97, 1.66]NRLow
Downgraded: risk of bias, imprecision
Depression remission (acute, 5 ≤ 12 weeks)
Antidepressants vs placebo
RR 1.54 [0.99, 2.41]NRLow
Downgraded: risk of bias, imprecision
Adverse events
Antidepressants vs placebo
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Depression severity ‐ overall (acute, 5 ≤ 12 weeks)
Antidepressants vs placebo
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Depression severity ‐ EPDS (acute, 5 ≤ 12 weeks)
Antidepressants vs placebo
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Treatment acceptability ‐ dropouts
Antidepressants vs placebo
RR 1.1 [0.74, 1.64]NRLow
Downgraded: risk of bias, imprecision
Child‐related outcomes
Antidepressants vs placebo
no estimate extractedNRNo studies

Antidepressants versus treatment as usual for postnatal depression

Population: women of any age, with PND up to 12 months
6 questions
OutcomeEffectEvidenceStatus / GRADE
Depression response or remission (acute, 5 ≤ 12 weeks)
Antidepressants vs treatment
no estimate extractedNRNo studies
Adverse events
Antidepressants vs treatment
no estimate extractedNRVery low
Downgraded: risk of bias, imprecision
Depression remission (early phase, < 5 weeks)
Antidepressants vs treatment
RR 2.31 [1.5, 3.54]NRVery low
Downgraded: risk of bias, imprecision
Depression severity ‐ mean EPDS score (early phase, < 5 weeks)
Antidepressants vs treatment
no estimate extractedNRVery low
Downgraded: risk of bias, imprecision
Treatment acceptability ‐ dropouts (early phase, < 5 weeks)
Antidepressants vs treatment
RR 1.71 [0.91, 3.23]NRVery low
Downgraded: risk of bias, imprecision
Child‐related outcomes
Antidepressants vs treatment
no estimate extractedNRNo studies

Antidepressants versus psychological interventions for postnatal depression

Population: women of any age, with PND up to 12 months
5 questions
OutcomeEffectEvidenceStatus / GRADE
Depression response or remission (acute phase, 5 ≤ 12 weeks)
Antidepressants vs psychological interventions
no estimate extractedNRNo studies
Adverse events
Antidepressants vs psychological interventions
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Depression severity ‐ mean EPDS score (acute phase, 5 ≤ 12 weeks)
Antidepressants vs psychological interventions
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Treatment acceptability ‐ dropouts
Antidepressants vs psychological interventions
RR 1.07 [0.24, 4.88]NRVery low
Downgraded: risk of bias, imprecision
Child‐related outcomes
Antidepressants vs psychological interventions
no estimate extractedNRNo studies

Antidepressants versus psychosocial interventions for postnatal depression

Population: women of any age, with PND up to 12 months
5 questions
OutcomeEffectEvidenceStatus / GRADE
Depression response or remission (acute phase, 5 ≤ 12 weeks)
Antidepressants vs psychosocial interventions
no estimate extractedNRNo studies
Adverse events
Antidepressants vs psychosocial interventions
no estimate extractedNRNo studies
Depression severity (acute phase, 5 ≤ 12 weeks)
Antidepressants vs psychosocial interventions
no estimate extractedNRNo studies
Treatment acceptability ‐ dropouts
Antidepressants vs psychosocial interventions
RR 1.94 [1.12, 3.35]NRVery low
Downgraded: risk of bias, imprecision
Child‐related outcomes
Antidepressants vs psychosocial interventions
no estimate extractedNRNo studies

Antidepressants versus any other pharmacological intervention for postnatal depression

Population: women of any age, with PND up to 12 months
8 questions
OutcomeEffectEvidenceStatus / GRADE
Depression response (acute phase, 5 ≤ 12 weeks)
Antidepressants vs any other pharmacological intervention
RR 0.98 [0.76, 1.27]NRVery low
Downgraded: risk of bias, imprecision
Depression remission (acute phase, 5 ≤ 12 weeks)
Antidepressants vs any other pharmacological intervention
RR 0.98 [0.68, 1.41]NRVery low
Downgraded: risk of bias, imprecision
Adverse events
Antidepressants vs any other pharmacological intervention
no estimate extractedNRNo studies
Depression response (early phase, < 5 weeks)
Antidepressants vs any other pharmacological intervention
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Depression remission (early phase, < 5 weeks)
Antidepressants vs any other pharmacological intervention
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Depression severity‐ mean HAM‐D scores (acute phase, 5 ≤ 12 weeks)
Antidepressants vs any other pharmacological intervention
no estimate extractedNRVery low
Downgraded: risk of bias, imprecision
Treatment acceptability ‐dropouts
Antidepressants vs any other pharmacological intervention
RR 1.74 [0.99, 3.06]NRVery low
Downgraded: risk of bias, imprecision
Child‐related outcomes
Antidepressants vs any other pharmacological intervention
no estimate extractedNRNo studies

Antidepressants versus any complementary medicine

Population: women of any age, with PND up to 12 months
6 questions
OutcomeEffectEvidenceStatus / GRADE
Depression response (acute phase, 5 ≤ 12 weeks)
Antidepressants vs any complementary medicine
RR 1.23 [0.71, 2.12]NRVery low
Downgraded: risk of bias, imprecision
Depression remission (acute phase, 5 ≤ 12 weeks)
Antidepressants vs any complementary medicine
RR 1.17 [0.44, 3.09]NRVery low
Downgraded: risk of bias, imprecision
Adverse events
Antidepressants vs any complementary medicine
no estimate extractedNRNo studies
Depression severity
Antidepressants vs any complementary medicine
no estimate extractedNRNo studies
Treatment acceptability
Antidepressants vs any complementary medicine
no estimate extractedNRNo studies
Child‐related outcomes
Antidepressants vs any complementary medicine
no estimate extractedNRNo studies